A group of bipartisan lawmakers are demanding an investigation into U.S. drug companies with reportedly troubling ties to China, according to a letter obtained by the Daily Caller News Foundation.
The lawmakers raised alarm to the Food and Drug Administration (FDA) in a Monday letter that they had identified some U.S. pharmaceutical companies as having worked with the Chinese military, raising concerns that U.S. intellectual property is being siphoned off by Beijing. The lawmakers also pointed out that several U.S. pharmaceutical companies also conducted clinical trials in the Xinjiang province of China, a region known for “genocide” against religious minorities, according to a letter sent by the lawmakers to the agency.
Read More